血糖監測儀（BGM設備）市場規模、佔有率和成長分析（按產品、應用和地區分類）－產業預測，2026-2033年

預計到 2024 年，血糖監測儀（BGM 設備）市場規模將達到 146.6 億美元，到 2025 年將達到 158.8 億美元，到 2033 年將達到 300.5 億美元，預測期（2026-2033 年）的複合年成長率為 8.3%。

全球血糖監測設備（BGM設備）市場正經歷顯著成長，這主要得益於糖尿病盛行率的不斷上升以及對精準可靠監測解決方案日益成長的需求。包括胰島素筆和持續血糖監測系統在內的設備技術進步，顯著改善了患者的治療效果和設備功能。醫療保健產業尤其致力於提供這些必要的工具，目前血糖監測設備已被納入多種醫療保險計劃，使患者更容易管理糖尿病。人們對血糖控制重要性以及血糖控制不佳相關風險的認知不斷提高，進一步推動了設備的普及。因此，血糖監測設備對於個人有效監測血糖值並及時調整治療方案至關重要。

血糖儀（BGM設備）市場促進因素

全球糖尿病患者數量的不斷成長是推動血糖監測（BGM）設備市場擴張的主要因素。人口老化以及生活方式和飲食習慣的改變是造成這一成長的主要因素，這些因素導致第1型和第2型糖尿病的發生率上升。這種激增凸顯了對有效血糖監測解決方案的迫切需求，以便控制血糖值並預防與疾病相關的潛在併發症。隨著越來越多的人希望透過定期監測來維護自身健康，對先進血糖監測（BGM）設備的需求持續顯著成長。

血糖儀（BGM設備）市場的限制

先進的血糖監測設備（尤其是連續血糖監測系統）高成本，對許多患者而言構成重大障礙。在缺乏醫療援助和報銷的地區，這些技術帶來的經濟負擔阻礙了其普及，尤其是在低收入者中。這種可近性不足導致市場細分程度降低，最終阻礙了血糖監測設備市場的整體成長。價格承受能力的差異進一步凸顯了製定更全面的定價策略和支持措施的必要性，以改善患者的可及性並促進這些重要監測工具的更廣泛應用。

血糖儀（BGM設備）市場趨勢

血糖監測（BGM）設備市場正加速向持續血糖監測（CGM）系統轉型，該系統可提供即時血糖值測量，並顯著改善糖尿病管理。這些先進設備具有更高的準確性、易用性和人性化的設計，使其成為個人和醫療保健提供者更具吸引力的選擇。隨著患者尋求更有效管理血糖值的方法，CGM系統在家庭和醫療機構中的應用正在迅速擴展。這一趨勢預示著醫療保健解決方案正朝著個人化方向發展，科技在其中發揮關鍵作用，幫助患者主導自身健康。

目錄

介紹

• 調查目標
• 定義
• 市場覆蓋範圍

調查方法

• 資訊收集
• 二手和一手資料資訊來源
• 市場規模預測
• 市場假設與限制

執行摘要

前景
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場動態
  • 促進要素
  • 機會
  • 抑制因素
  • 任務
• 波特分析

關鍵市場考察

• 技術分析
• 定價分析
• 價值鏈分析
• 市場生態系統
• 貿易分析
• 供應鏈分析
• 案例研究分析
• 專利分析
• 客戶和購買標準分析
• 監管環境
• 創新矩陣
• 主要投資分析
• 關鍵成功因素
• 競爭程度

血糖儀（BGM設備）市場依產品分類

• 血糖監測儀
  • 單點血糖儀
  • 連續血糖監測系統
  • 感應器
  • 發送器和接收器
  • 外接顯示器
• 血糖監測試紙
• 《採血針》

按應用分類的血糖儀（BGM設備）市場

• 醫院和診所
• 診斷中心
• 家庭環境

按地區分類的血糖儀（BGM設備）市場

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲（MEA）
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭格局

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市佔率（2025 年）

主要企業簡介

• Abbott（US）
• Medtronic plc（Ireland）
• F. Hoffmann-La Roche Ltd（Switzerland）
• Dexcom, Inc.（US）
• Sanofi（France）
• Novo Nordisk（Denmark）
• Insulet Corporation（US）
• Ypsomed Holdings（Switzerland）
• Glysens Incorporated
• ARKRAY, Inc.（Japan）
• Bayer AG（Germany）
• AgaMatrix, Inc.（US）
• Trividia Health, Inc.（US）
• MediWise Ltd.（UK）
• DiaMonTech AG（Germany）
• B. Braun Melsungen AG（Germany）
• Sinocare, Inc.（China）
• Nipro Corporation（Japan）
• Menarini Diagnostics（Italy）
• Beurer GmbH（Germany）
• Prodigy Diabetes Care, LLC（US）
• Omron Healthcare, Inc.（Japan）

Blood Glucose Monitoring Devices Market size was valued at USD 14.66 Billion in 2024 and is poised to grow from USD 15.88 Billion in 2025 to USD 30.05 Billion by 2033, growing at a CAGR of 8.3% during the forecast period (2026-2033).

The global market for blood glucose monitoring devices is experiencing significant growth, driven by the escalating incidence of diabetes and the rising demand for precise and dependable monitoring solutions. Technological advancements in devices, including insulin pens and continuous glucose monitoring systems, have improved patient outcomes and device functionality. Notably, the healthcare sector provides accessibility to these essential tools, as glucose monitoring devices are covered under various health insurance plans, facilitating patient management of diabetes. Increased awareness of the critical need for glycemic control and the risks associated with unmanaged diabetes is further propelling device adoption. Consequently, blood glucose meters are becoming vital for individuals to monitor their blood sugar levels effectively, ensuring timely adjustments in their treatment regimens.

Top-down and bottom-up approaches were used to estimate and validate the size of the Blood Glucose Monitoring Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Blood Glucose Monitoring Devices Market Segments Analysis

Global Blood Glucose Monitoring Devices Market is segmented by Product, Application, and region. Based on Product, the market is segmented into Blood Glucose Monitors, Glucose Monitoring Strips, and Lancets. Based on Application, the market is segmented into Hospitals and Clinics, Diagnostic Centers, and Home Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Blood Glucose Monitoring Devices Market

The increasing prevalence of diabetes globally serves as a key catalyst for the expansion of the blood glucose monitoring devices market. Factors contributing to this rise include an aging population, along with shifts in lifestyle and eating habits, which have led to higher incidences of both type 1 and type 2 diabetes. This upsurge underscores the urgent need for effective glucose monitoring solutions to manage blood sugar levels, thereby preventing potential complications associated with the condition. As more individuals seek to maintain their health through regular monitoring, the demand for advanced blood glucose monitoring devices continues to grow significantly.

Restraints in the Blood Glucose Monitoring Devices Market

The high cost of advanced blood glucose monitoring devices, particularly continuous glucose monitoring systems, poses a significant barrier to accessibility for many patients. In areas lacking healthcare subsidies or reimbursement options, the financial burden associated with these technologies restricts their adoption, particularly among low-income populations. This limited accessibility results in a reduced market segment, ultimately stunting the overall growth of the blood glucose monitoring devices market. The disparity in affordability further emphasizes the need for more inclusive pricing strategies and support initiatives to enhance patient access and drive wider acceptance of these essential monitoring tools.

Market Trends of the Blood Glucose Monitoring Devices Market

The Blood Glucose Monitoring Devices market is increasingly witnessing a shift towards Continuous Glucose Monitoring (CGM) systems, which offer real-time glucose readings and significantly improve diabetes management. These advanced devices enhance accuracy, usability, and user-friendly designs, making them more appealing to both individuals and healthcare providers. As patients seek more efficient ways to monitor their glucose levels, the adoption of CGM systems is proliferating in both home settings and clinical institutions. This trend is indicative of a broader movement towards personalized healthcare solutions, where technology plays a critical role in empowering patients to take control of their health.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Trade Analysis
• Supply chain Analysis
• Case study Analysis
• Patent Analysis
• Customer & Buying Criteria Analysis
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Blood Glucose Monitoring Devices Market by Product

• Market Overview
• Blood Glucose Monitors
  • Single Point Blood Glucose Meters
  • Continuous Glucose Monitoring Systems
  • Sensors
  • Transmitter and Receivers
  • External Monitor
• Glucose Monitoring Strips
• Lancets

Blood Glucose Monitoring Devices Market by Application

• Market Overview
• Hospitals and Clinics
• Diagnostic Centers
• Home Settings

Blood Glucose Monitoring Devices Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2025

Key Company Profiles

• Abbott (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dexcom, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed Holdings (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glysens Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARKRAY, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AgaMatrix, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trividia Health, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MediWise Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaMonTech AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sinocare, Inc. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Menarini Diagnostics (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beurer GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prodigy Diabetes Care, LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omron Healthcare, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments